These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 20622270

  • 1. [The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia].
    Chachua T, Abuladze G, Nebieridze M.
    Georgian Med News; 2010 Jun; (183):18-21. PubMed ID: 20622270
    [Abstract] [Full Text] [Related]

  • 2. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356
    [Abstract] [Full Text] [Related]

  • 3. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias].
    Furlanello F, Vergara G, Dal Forno P, Disertori M, Inama G.
    G Ital Cardiol; 1984 May 01; 14(5):379-80. PubMed ID: 6468821
    [Abstract] [Full Text] [Related]

  • 4. [Anti-arrhythmia efficacy of propafenone per os in the prevention of paroxysmal supraventricular arrhythmia resistant to class Ia agents].
    Boutaud P, Guillem JP, Maarek-Charbit M, Amiel A, Ciber M, Herpin D, Demange J.
    Ann Cardiol Angeiol (Paris); 1989 Jan 01; 38(1):37-42. PubMed ID: 2930150
    [Abstract] [Full Text] [Related]

  • 5. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M, Cullen MT, Casadei G.
    Eur Heart J; 1995 Dec 01; 16(12):1943-51. PubMed ID: 8682031
    [Abstract] [Full Text] [Related]

  • 6. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
    Gambhir DS, Bhargava M, Arora R, Khalilullah M.
    Indian Heart J; 1995 Dec 01; 47(3):237-43. PubMed ID: 7558090
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological treatment of young children with permanent junctional reciprocating tachycardia.
    van Stuijvenberg M, Beaufort-Krol GC, Haaksma J, Bink-Boelkens MT.
    Cardiol Young; 2003 Oct 01; 13(5):408-12. PubMed ID: 14694933
    [Abstract] [Full Text] [Related]

  • 8. [Electropharmacological test with class-I C drugs in paroxysmal supraventricular re-entrant tachycardia: is a negative result with a drug predictive of the ineffectiveness of other drugs of the same class?].
    Inama G, Furlanello F, Braito G, Guarnerio M, Vergara G.
    G Ital Cardiol; 1991 Feb 01; 21(2):131-8. PubMed ID: 1907937
    [Abstract] [Full Text] [Related]

  • 9. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
    Rae AP.
    Am J Cardiol; 1998 Oct 16; 82(8A):59N-65N. PubMed ID: 9809902
    [Abstract] [Full Text] [Related]

  • 10. [Drug therapy of cardiac arrhythmias 199].
    Dietz A, Manz M.
    Fortschr Med; 1997 Nov 30; 115(33):32, 34-6, 38. PubMed ID: 9480278
    [Abstract] [Full Text] [Related]

  • 11. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
    Lévy S, Ricard P.
    Eur Heart J; 1997 May 30; 18 Suppl C():C27-32. PubMed ID: 9152672
    [Abstract] [Full Text] [Related]

  • 12. [Efficiency of antiarrhythmic drugs of class 1C and isoptin in paroxysmal supraventricular tachycardia].
    Koshumbaeva KM, Tulenov MT, Belokopit IN.
    Klin Med (Mosk); 2002 May 30; 80(2):57-60. PubMed ID: 11898726
    [Abstract] [Full Text] [Related]

  • 13. [The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique].
    Li Q, Wang Z, Peng D.
    Hunan Yi Ke Da Xue Xue Bao; 1997 May 30; 22(2):123-6. PubMed ID: 9868052
    [Abstract] [Full Text] [Related]

  • 14. [The prospective evolution of the efficacy of antiarrhythmia therapy in paroxysmal supraventricular tachycardia in patients with the ventricular pre-excitation syndrome].
    Fomina IG, Iankin VV.
    Klin Med (Mosk); 1992 Jan 30; 70(1):26-32. PubMed ID: 1608203
    [Abstract] [Full Text] [Related]

  • 15. Intravenous calcium chloride in the conversion of paroxysmal supraventricular tachycardia to normal sinus rhythm.
    O'Brien JF, Tremml GP, Falk JL.
    Am J Emerg Med; 1996 Jan 30; 14(1):50-2. PubMed ID: 8630157
    [Abstract] [Full Text] [Related]

  • 16. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P, Frank R, Fontaine G, Tonet J, Tageddine R, Benassar A, Turlure A, Jacquemin M, Laborde JP.
    Arch Mal Coeur Vaiss; 1995 Dec 30; 88(12):1869-74. PubMed ID: 8729368
    [Abstract] [Full Text] [Related]

  • 17. Paroxysmal supraventricular tachycardia: experience with propafenone.
    Santinelli V, De Paola M, Turco P, Smimmo D, Chiariello M.
    Angiology; 1989 Jun 30; 40(6):563-8. PubMed ID: 2719341
    [Abstract] [Full Text] [Related]

  • 18. [Preventive efficacy of propafenone, its effect on functional state of the heart during long-term treatment of patients with paroxysmal atrioventricular arrhythmias].
    Koshumbaeva KM, Belokopit IN, Makhanov DI, Nugmanova MN.
    Kardiologiia; 2006 Jun 30; 46(11):63-5. PubMed ID: 17159883
    [Abstract] [Full Text] [Related]

  • 19. [Paroxysmal supraventricular tachycardia in pregnancy. Value of adenosine and other anti-arrhythmia agents].
    Hösl P, Rust M, Johannigmann J, Schmidt G.
    Geburtshilfe Frauenheilkd; 1996 Jun 30; 56(6):313-6. PubMed ID: 8766489
    [Abstract] [Full Text] [Related]

  • 20. [Supraventricular paroxysmal tachycardias during pregnancy: the therapeutic tactics and prognosis].
    Mravian SR, Petrukhin VA.
    Klin Med (Mosk); 2007 Jun 30; 85(4):17-20. PubMed ID: 17564030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.